Chemotherapy for newly diagnosed and relapsed advanced ovarian cancer
- 1 November 2003
- journal article
- review article
- Published by Elsevier in Seminars in Oncology Nursing
- Vol. 19, 25-35
- https://doi.org/10.1053/j.soncn.2003.09.003
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Impact of Ovarian Cancer Perceived by WomenCancer Nursing, 2003
- Women’s Experiences With Recurrent Ovarian CancerCancer Nursing, 2003
- Combination Chemotherapy With Carboplatin and Docetaxel in the Treatment of Cancers of the Ovary and Fallopian Tube and Primary Carcinoma of the PeritoneumJournal of Clinical Oncology, 2001
- Women’s Perspectives Regarding the Impact of Ovarian CancerCancer Nursing, 2000
- Estimates of the worldwide incidence of 25 major cancers in 1990International Journal of Cancer, 1999
- Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trialsBritish Journal of Cancer, 1998
- Quality of Life in Women with Ovarian CancerWestern Journal of Nursing Research, 1997
- Chemotherapy-associated neurotoxicity: an important side effect-impacting on quality, rather than quantity, of lifeZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1994